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Abstract 
The aim of the present study was to evaluate the role of parental longevity and parental 
cardiovascular disease (CVD) history, in CVD risk and successful ageing of a random 
sample of older adults living in the Mediterranean basin and who participated in the 
MEDIS (MEDiterranean ISlands) study. During 2005-2011, 2663 elders were voluntarily 
enrolled. A multidimensional successful ageing index consisting of 10 components was 
used. Paternal and maternal longevity was defined as those older participants of whom 
both parents lived above the age of 90 years. The burden of CVD related factors (CVD 
RFs) was calculated as the total score of four major CVD RFs (range 0-4). After 
adjustment, parental longevity was inversely associated with the burden of CVD RFs 
(p=0.04). Moreover, parental longevity was positively associated with the older adults’ 
successful ageing score [b-coefficient (95% CI): 0.38 (0.06 to 0.71)]. Parent’s long-living 
was revealed as an important factor for successful ageing and for reduced CVD risk, 
suggesting that further research is needed in the genetic pre-disposition of longevity.  
 
Keywords: parental longevity; successful ageing; cardiovascular disease; older adults, 
Mediterranean basin 
 
 
 
 
 
3 
 
Introduction 
The principals of longevity, and healthy and successful ageing remain among the major 
challenges of public health1. Until now, many studies have proposed that longevity 
follows a familial pathways2 and could be inherited. According to researchers, a complex 
phenotype is accompanying the ‘long-livers’ and more particularly the centenarians, as a 
result of their improved capacity to physiologically adapt throughout the various life 
stages3,4. Specifically, long-liver groups, like the centenarians, are characterized by 
delayed onset of cardiovascular disease (CVD), certain cancers, dementia, as well as 
cognitive and functional impairment.5-9. Following the healthy status of their long-liver 
parents their offspring’s are experiencing a similar long-living pathway. Previous 
findings indicate that long-livers’ offspring’s are having lower risk for CVD events and 
CVD related factors (CVD RFs) (i.e. hypertension, diabetes mellitus, etc.)10,11 and thus 
have a significant survival advantage12-14. 
In parallel, it is well known that cardiovascular health encompasses both familial 
(genetic) components as well as environmental factors15-17. Various studies have 
indicated the role of maternal and paternal CVD history on the CVD health status of their 
offspring16-17. Previous studies suggest that parental long-living is beneficially related to 
their offspring’s health status; however the adjustment for parental clinical history is 
sparse18. Clearly the process of longevity is quite complex and is associated with a variety 
of factors, not only with physical health. Successful ageing is a concept which is 
considered as a low probability of disease and disability, high cognitive and physical 
capacity, active participation throughout various social activities and represents the 
aforementioned complexity in the longevity process19-20. Until now, to the best of our 
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knowledge, there is a lack of epidemiological evidence on the role of parental longevity 
and CVD history in successful ageing. 
Given the complexity of the human longevity and ageing pathway, together with 
the lack of data among Mediterranean populations, the aim of the present study was to 
evaluate the role of parental longevity and parental CVD history, in CVD risk and 
successful ageing of a random sample of older adults living in the Mediterranean basin 
and who participated in the MEDIS (MEDiterranean ISlands) study. The MEDIS study 
sample encompasses 2 of the already reported high life expectancy areas in the world (i.e. 
the islands of Ikaria and Sardinia). In addition, the selected older Mediterranean 
population has rarely been studied in the last 4 decades; a fact that makes this survey of 
major importance, as it included two of the islands (i.e. Corfu and Crete) where Ancel 
Keys and his colleagues from the Seven Countries Study first observed the basic 
components of longevity21.  
 
Methods 
The MEDIS study sample 
During 2005-2011, a population-based, multi-national, convenience sampling was 
performed to voluntarily enroll older people from 21 Mediterranean islands (the target 
sample size was 300 people from the Republic of Cyprus, 250 from Malta and 150 from 
each of the other islands/areas): Republic of Cyprus (n=300), Malta (n=250), Sardinia 
(n=60), Sicily (n=50), Mallorca and Menorca (n=111) and the Greek islands of Lesvos 
(n=142), Samothrace (n=100), Cephalonia (n=115), Crete (n=131), Corfu (n=149), 
Limnos (n=150), Ikaria (n=76), Syros (n=151), Naxos (n=145), Zakynthos (n=103), 
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Salamina (n=147), Kassos (n=52), Rhodes and Karpathos (n=149), Tinos (n=129), as 
well as from the rural region of Mani (n=153) (a southern Greek peninsula). According to 
the study protocol, individuals were not eligible for inclusion if they resided in assisted-
living centers, had a clinical history of CVD or cancer, or had lived away from the island 
or region for a considerable period of time during their lives (i.e. >5 years); these 
exclusion criteria were applied because the study aimed to assess lifestyle habits that 
were not subject to modifications due to existing chronic health conditions or by 
environmental factors, other than living milieu. A group of health scientists (physicians, 
dietitians, nutritionists and nurses) with experience in field investigation collected the 
required information using a quantitative questionnaire and standard procedures.  
The study followed the ethical considerations provided by the World Medical 
Association (52nd WMA General Assembly, Edinburgh, Scotland, October 2000). The 
Institutional Ethics Board of Harokopio University approved the design and procedures 
of the study (reference No. 16/19-12-2006). Participants were informed about the aims 
and procedures of the study and gave their consent prior to being interviewed. 
Evaluation of clinical characteristics  
All of the measurements carried out in the different study centres were standardized and 
the questionnaires used were translated in all cohort languages following the World 
Health Organization (WHO) translation guidelines for tools’ assessment.22 Weight, height 
and waist circumference were measured using a standard protocol; body mass index 
(BMI) was calculated as the ratio of weight by height squared (kg/m2). Overweight was 
defined as BMI between 25 and 29.9 Kg/m2 and obesity was defined as BMI > 29.9 
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Kg/m2. Diabetes mellitus (type 2) was determined by fasting plasma glucose tests and 
was analyzed in accordance with the American Diabetes Association diagnostic criteria 
(glycated haemoglobin A1C >6.5% or fasting blood glucose levels greater than 125 
mg/dl or 2-h plasma glucose >200 mg/dl during an oral glucose tolerance test-OGTT- or 
a random plasma glucose >200 mg/dl, or by a prior diagnosis of diabetes). Participants 
who had blood pressure levels 140/90 mmHg or used antihypertensive medications were 
classified as hypertensive. Fasting blood lipid levels [high density lipoprotein (HDL-) and 
low density lipoprotein (LDL-) cholesterol and triglycerides)] were also recorded and 
hypercholesterolemia was defined as total serum cholesterol levels >200 mg/dL, or the 
use of lipid-lowering agents according to the National Cholesterol Education Program-
Adult Treatment Panel III (NCEP ATPIII) guidelines.23  
Parental longevity was defined as those older participants of whom both parents 
were long-livers, beyond the age of 90 years. Moreover, maternal and paternal history of 
diabetes type II, hypertension and hypercholesterolemia were recorded. No information 
on maternal and paternal history of obesity was collected. A cumulative paternal and 
maternal “CVD history index” was developed, summing the 3 health-specific, binary 
variables mentioned before (a score of 1 was given for each additional related factor: 
hypertension, hypercholesterolemia, diabetes type II, so theoretical range was 0-3). 
Further classification was applied. Specifically, those with score 0 were classified with no 
maternal and paternal CVD history, while those with score 1 to 3 were grouped as having 
maternal and paternal CVD history. 
Evaluation of dietary habits, socio-demographic and other lifestyle characteristics of 
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the participants 
Dietary habits were assessed through a semi-quantitative, validated and reproducible 
food-frequency questionnaire.24 Furthermore, consumption of various alcoholic 
beverages (i.e. wine, beer, whiskey, vodka, and the traditional ouzo, tsipouro and retsina) 
was measured in terms of wineglasses per day, adjusted for ethanol intake (e.g. one 100 
ml glass of wine was considered to have 12% ethanol) and classified for the present 
analyses, into 0 for no alcohol consumption, 1 for alcohol consumption of at least 1 
glass/week. To evaluate the level of adherence to the Mediterranean diet, the 
MedDietScore (theoretical range 0-55) was used.25 
Basic socio-demographic characteristics, such as age, gender, years of schooling, 
financial status, as well as lifestyle characteristics, such as smoking habits and physical 
activity status, were recorded. Regarding financial status, the participants were asked to 
report their mean income during the previous three years using a four-point scale (low, 
inadequate to cover daily expenses = 1, medium, trying hard to cover daily expenses = 2, 
good, adequate to cover daily expenses = 3, very good, very adequate to cover daily 
expenses = 4). This scale was decided upon because of the variety of the populations 
studied, as well as the common difficulty of accessing exact financial data. The 
participants who were in the upper category were classified as participants with high 
financial status, while all the others were classified as low and medium financial status 
(high vs. low-medium financial status). Current smokers were defined as smokers at the 
time of the interview. Former smokers were defined as those who had previously smoked, 
but had not done so for a year or more. The remaining participants were defined as 
occasional or non-current smokers. Physical activity was evaluated in metabolic 
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equivalent of task (MET) -minutes per week, using the shortened, and validated Greek 
version of the self-reported International Physical Activity Questionnaire (IPAQ)26 
translated in all the cohort´s languages. As minimally active or “health-enhancing 
physical activity (HEPA) active” were classified individuals who reported at least 3 
MET-minutes per week.  Furthermore, the weekly frequency of physical activity was 
recorded. Symptoms of depression during the previous month were assessed using the 
validated Greek version (also translated in all the cohort´s languages) of the shortened, 
self-report Geriatric Depression Scale (GDS) (range 0-20).27 Moreover, in order to 
evaluate the older adults’ social participation, the weekly frequency of their social 
activities with their family, their friends as well as their yearly frequency of excursions 
were recorded. 
Further details about the MEDIS study protocol may be found elsewhere.28 
Evaluated outcomes 
Following the multi-dimensional approach to successful ageing already reported by 
several experts29 and the MEDIS study group,20 10 components (i.e. education, financial 
status, physical activity, BMI, GDS score, participation in social activities with friends, 
with family, yearly excursions, CVD RFs score and MedDietScore) were incorporated for 
the measurement of successful ageing. The composed successful ageing index was 
represented as the cumulative score of the 10 components (theoretical range 0-10); 
specifically, individual ratings (from 0 to 1) in each of the 10 components were assigned, 
according to their positive or negative (i.e. reverse scoring) influence on successful 
ageing, according to the current literature.20  
Moreover, a cumulative score indicating the overall burden of CVD RFs of the 
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older participants, was calculated (a score of 1 was given for each additional risk factor: 
hypertension, hypercholesterolemia, diabetes and obesity, so the theoretical range was 0-
4). 
Statistical analysis 
Continuous variables are presented as mean ± standard deviation (SD) and categorical 
variables as frequencies. Comparisons of continuous variables between groups of study 
were performed using the independent samples t-test (for the normally distributed 
variables), or the Mann-Whitney U-test and the Kruskall-Wallis test (for the skewed 
variables). Associations between categorical variables were tested using the chi-square 
test. Nested multiple logistic regression models were applied to estimate, for an off-
spring, the odds of having overall CVD RF ‘morbidity index’ (0-2 related factors vs. 3-4 
related factors), taking into account other participants' characteristics (i.e. age, sex, 
education and financial status, living alone, former smoking habits, physical activity, 
adherence to the Mediterranean diet, alcohol consumption, parental longevity, maternal 
and paternal CVD history). Nested linear regression models were also applied in order to 
further evaluate the association between various factors, that were potentially associated 
with the odds of having overall 3-4 CVD factors, (i.e. socio-demographic, bio-clinical, 
lifestyle factors, parental longevity, maternal and paternal CVD history) and the level of 
successful ageing. Colinearity was tested using the Variance Inflation Factor criterion 
(VIF; values >4 suggested colinearity between independent variables and one of them 
was excluded from the model). The assumption of homoscedasticity was tested by 
plotting the scatter plot of standardised residuals over the predicted score values. Results 
from linear regression models are presented as b-coefficients and their 95% Confidence 
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Intervals. No correction for multiple comparisons testing was performed, because the 
tested hypotheses were independent. All reported p-values were based on two-sided tests. 
SPSS software (version 20) was used for all calculations (IBM Statistics, Greece). 
 
Results 
Among the MEDIS sample, paternal longevity (father lived >90 years) was 9% and 
maternal longevity (mother lived >90 years) was 12%. When the 7 geographical areas of 
the participants were taken into account (West Mediterranean, Ionian, Aegean, Saronikos 
islands, Crete island, Mani, and Cyprus Republic), the inhabitants of the Republic of 
Cyprus had the highest prevalence of paternal and maternal longevity (i.e. 19 and 22%) 
while the participants living in the islands of West Mediterranean (Malta, Sardinia, Sicily, 
Balearic islands) had the lowest paternal longevity (i.e. 4%) and Saronikos islands had 
the lowest maternal longevity (i.e. 5%) (p<0.001). Parental longevity regarding the 7 
geographical areas is presented in Table 1. When rural and urban areas were compared, a 
significant difference emerged with regard to the proportion of older adults exhibiting 
paternal longevity (both mother and father lived >age of 90 years) (6 vs. 5%, p=0.008). 
Moreover, older adults living in urban areas had a higher burden of parental CVD history 
as opposed to those living in rural areas (i.e. 52 vs. 37%, p<0.001).  
[Table 1] 
Analytical demographic, behavioral, clinical and lifestyle characteristics of the 
sample by parental (i.e. maternal, paternal and parental) CVD history are summarized in 
Table 2. Compared with older adults with no parental CVD history, those with parental 
CVD history, had a higher prevalence of hypertension (p<0.001), diabetes type II 
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(p<0.001), hypercholesterolemia (p<0.001), a higher burden of CVD RF (p<0.001) and 
were classified within high financial status (p<0.002). No consistent differences were 
observed, however, between the groups with regard to their BMI level, smoking habits, 
living alone, alcohol consumption, adherence to the Mediterranean diet, physical activity 
and successful ageing. 
[Table 2] 
Age, gender, education and high financial status, living alone, physical activity, 
smoking habits, alcohol consumption and adherence to the Mediterranean diet, adjusted 
logistic regression analysis showed that older adults with parental longevity were 0.4-
times less likely to have an increased burden of CVD RF, as opposed to those with no 
parental longevity (95%CI 0.16 to 0.98) (model 1). The latter model was further adjusted 
for maternal and paternal CVD history. When these factors were taken into account 
parental longevity was not associated any more with the burden of CVD RFs among the 
older adults (model 2). Moreover, in this model the habit of consuming alcohol appears to 
offer some protection against the accumulation of factors associated with CVD.   
[Table 3] 
The above mediating association among parental longevity and parental CVD 
history was further tested throughout the wider concept of successful ageing. Specifically, 
after adjusting for age, gender, smoking habits and alcohol consumption, parental 
longevity was positively associated with the  successful ageing score [b-coefficient (95% 
CI): 0.38 (0.06 to 0.71)] of islanders (model 1). However, when paternal and maternal 
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CVD history was taken into account, the association of parental longevity with the older 
adults’ successful ageing score disappeared (model 2). 
[Table 4] 
 
Discussion 
The present study revealed that parental longevity was inversely associated with their 
offspring’s burden of CVD risk, irrespective of age, gender, education and high financial 
status, living alone, physical activity, smoking habits, alcohol consumption and 
adherence to the Mediterranean diet. In addition, a positive association among parental 
longevity and the older adult’s successful ageing level was reported. However, the latter 
findings became non-significant when paternal and maternal CVD RF history was 
considered in the analysis. The confounding role of paternal and maternal CVD history 
on the relationship between parental longevity and older adult’s burden of CVD RF and 
successful ageing status could imply that it is not only the possible inherited factor of 
longevity that promotes successful ageing and CVD health, but also the burden of 
parental CVD RFs. All of the aforementioned relationships, especially among elderly 
Mediterranean populations, have rarely been studied. 
Despite the lack of previous findings regarding parental longevity and CVD 
health and successful ageing among Mediterranean populations, a number of studies have 
previously reported that long-livers offspring’s also enjoy a ¨healthy¨ longer life. More 
specifically, that the offspring of long-livers have lower risk for CVD, as well as various 
CVD RFs (i.e. hypertension, diabetes mellitus, etc)10, 11. Within our data analysis, a 
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number of components as well as parental longevity and their offspring’s burden of CVD 
RFs were explored to reveal the positive role of parental longevity on their offspring’s 
CVD health (model 1). According to several researchers, the aforementioned favorable 
association could be the result of specific disease genes prevalent in long-livers. Various 
types of allele genes have been proposed.30-32. Furthermore, the role of genes in 
minimizing the “speed” of ageing and offering protection against age-related diseases 
could be an additional possible explanation33. Recently the role of different pathways 
(gender, etc.) in ageing and longevity, have been reported34. Throughout the multivariate 
analysis, being female was associated with higher CVD morbidity. The latter finding is in 
accordance with previous results where females were living longer with higher burden of 
disease compared with males35. 
Research findings, however, lend support to the existence of genetic determinants 
for various CVD RFs such as diabetes mellitus, metabolic syndrome and others16-17. 
Various epidemiologic results suggest that parental, and in general familial aggregation 
of CVD events, is an additional strong determinant36. Although several international 
organizations23 include parental CVD history as an independent factor in the assessment 
of CVD health, until now, it is rarely considered in the analysis of previous studies18. For 
the first time, this study extends the analysis by including the maternal and parental CVD 
history (model 2), to show that the beneficial effect of parental longevity on offspring’s 
CVD health thus disappears. This finding indicates that the above mentioned positive 
contribution of parental longevity could be mediated to those offspring’s who have an 
increased maternal and paternal burden of CVD RFs. 
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It has been suggested that the process of long-living reflects complex 
interrelations among multi-dimensional factors, which are represented throughout the 
successful ageing concept20. Successful ageing has been associated with lower mortality 
rates and better health outcomes29. The analysis of the MEDIS data revealed a beneficial 
effect of parental longevity on their offspring’s successful ageing. However this 
association was not significant any more after the inclusion of parental CVD RF history 
(model 2). Until now, despite the sound evidence supporting the beneficial effect of 
parental longevity on various health indicators18, the information about its role in the 
level of successful ageing is sparse. Genomics, metabolomics37, epigenetics38, have been 
proposed as potential longevity pathways and could beneficially contribute to the 
favorable level of successful ageing. Taking into account the aforementioned, the 
offspring of long-livers seem to have a better successful ageing status, and a reduced risk 
for CVD age-related morbidities than the offspring of non-long-lived parents. This 
possible familial longevity and CVD health pathway raises some concerns about the need 
for early prevention measures in order to promote healthy long-living, specifically among 
the offspring of non-long-lived parents and of parents with increased CVD morbidity. 
However, further studies are needed in the genetic pre-disposition of longevity, 
successful ageing and the role of parental burden of CVD RFs. 
Strengths and limitations 
The present study has several strengths. It is one of the few to evaluate the 
association of various factors (clinical, socio-demographic and lifestyle), parental 
longevity and CVD history of a large sample of ‘healthy’, independently-living older 
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people in the Mediterranean basin. Among the limitations, is the fact that this is a cross-
sectional study limits the potential for aetiological conclusions. Estimation of successful 
ageing and of total CVD risk among elders is a difficult task20,39. The cumulative 
successful ageing index, as well as the CVD scores that were used here by simply adding 
the presence of the common determinants of the individuals may not accurately estimate 
the successful ageing status and the CVD risk of these individuals. Also, in this study 
there was the potential of recall bias, particularly in the assessment of parental CVD 
history.   
Conclusions 
Parental longevity seems to constitute an important factor of successful ageing and CVD 
health of Mediterranean older adults. Our results suggest that older adults with long-lived 
parents retain a healthier CVD profile in their later life; a fact that further enhances the 
familial pathway of longevity and successful ageing. However, further studies are needed 
to better address this interesting question on the role of hereditary in CVD health and 
successful ageing. 
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Table 1.  Parental longevity (both long-lived parents) among different geographical areas 
of the MEDIS study. 
Geographical areas Parental Longevity 
Aegean Islands (%)* 4 
Island of Crete (%)  2 
Ionian Islands (%)* 4 
Republic of Cyprus (%)  7 
West Mediterranean Islands (%)* 2 
Saronikos Islands (%)*  2 
South Peloponnesus (%)* 7 
* Aegean area includes the islands of: Lesvos, Samothrace, Limnos, Ikaria, Syros, Naxos, Kassos, Rhodes 
and Karpathos and Tinos. Ionian area includes the islands of: Cephalonia, Corfu and Zakynthos; West 
Mediterranean area includes the islands of:  Malta, Sardinia, Sicily, Mallorca and Menorca; Saronikos area 
are includes the island of: Salamina; South Peloponnesus area includes the rural area of Mani.  
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Table 2. Demographic, behavioral and lifestyle characteristics of the Multi-national MEDIS sample, by parental CVD history.  
 No Maternal  
CVD history  
(n=905) 
Maternal   
CVD history 
(n=305) 
P No Paternal 
CVD history 
(n=803) 
Paternal CVD 
history 
(n=407) 
P No Parental 
CVD history 
(n=654) 
Parental CVD 
history 
(n=553) 
P 
Age 74.5+74 72.9+6.9 0.001 74.7+7.4 72.9+6.9 <0.001 75.2+7.5 72.8+6.9 <0.001 
Sex (male %) 48 49 0.70 51 41 0.001 52 43 0.001 
BMI (kg/m2) 29.0+11.0 28.7+4.6 0.72 28.8+11.4 29.2+4.8 0.53 28.9+12 28.9+5.0 0.99 
Education (years of schooling) 6.4+4.0 7.2+4.1 0.10 6.5+4.2 6.8+3.9 0.35 6.4+4.2 6.8+3.9 0.18 
High financial status (%) 15 17 0.43 11 25 <0.001 11 20 0.002 
Living alone (%)   26 22 0.19 24 28 0.14 24 28 0.44 
Former smoking habits (%)  37 35 0.80 38 33 0.22 40 32 0.06 
Physical activity (%) 65 47 0.50 48 80 0.16 49 72 0.30 
MedDietScore (0-55) 33.4+4.6 32.9+4.6 0.16 33.5+4.5 33.0+4.7 0.21 33.5+4.7 33.1+4.7 0.25 
Alcohol consumption (%) 47 50 0.28 47 49 0.51 45 50 0.09 
Hypertension (%) 59 70 0.001 55 74 <0.001 54 71 <0.001 
Diabetes Mellitus (%) 22 35 <0.001 22 31 0.001 20 32 <0.001 
Hypercholesterolemia (%) 49 64 <0.001 45 68 <0.001 42 65 <0.001 
CVD risk score (0-4) 1.6+1.1 2.0+1.1 <0.001 1.5+1.1 2.1+1.1 <0.001 1.5+1.1 2.0+1.1 <0.001 
Successful ageing index (0-10) 2.5±1.3 2.6±1.4 0.80 2.5±1.3 2.7±1.4 0.05 2.5±1.3 2.6±1.4 0.75 
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Table 3. Results from nested multiple logistic regression models performed to evaluate the 
association of various socio-demographic, bio-clinical, lifestyle characteristics and parental longevity 
as well as CVD history of the multi-national MEDIS study participants in relation to the overall CVD 
RF ‘morbidity index’+  (0-2 related factors vs. 3-4 related factors). 
 
Model 1 Model 2 
 
OR (95%CI) OR (95%CI) 
Paternal Longevity (yes vs. no) 0.40* (0.16; 0.98) 0.88 (0.21; 3.64) 
Age (per 1 year) 0.96** (0.94; 0.98) 0.99 (0.96; 1.03) 
Sex (men vs. women) 0.52** (0.33; 0.82) 0.53* (0.28; 1.00) 
Education status (years of school) 0.93** (0.88; 0.98) 0.95 (0.88-1.03) 
High financial status (yes vs. no) 0.83 (0.52; 1.32) 0.53 (0.24; 1.16) 
Living alone (yes vs. no) 0.81 (0.56; 1.16) 0.74 (0.41; 1.23) 
Physical activity (yes vs. no) 1.05 (0.74; 1.49) 0.92 (0.55; 1.54) 
MedDietScore (change per unit) 1.01 (0.97; 1.06) 1.03 (0.96; 1.11) 
Former smoking (yes vs. no) 1.12* (1.05; 1.20) 1.85 (0.93; 3.67) 
Alcohol consumption (yes vs. no) 0.66* (0.46; 0.95) 0.55* (0.32; 0.93) 
Maternal CVD history (yes vs. no) - - 0.79 (0.45; 1.39) 
Paternal CVD history (yes vs. no) - - 1.98* (1.19; 3.29) 
Abbreviations: OR: odds ratio, CI: confidence interval, CVD RF ‘morbidity index’: score one was given 
for each additional risk factor: hypertension, hypercholesterolemia, diabetes and obesity, theoretical range 
0-4). 
* p<0.05, ** p<0.01, *** p<0.001  
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Table 4. Results from nested linear regression models performed to evaluate the association of socio-
demographic, lifestyle characteristics, parental longevity and CVD history, that were found to be 
previously associated with participants’ CVD related factors, in relation to the level successful ageing. 
 Model 1 Model 2 
 b-coefficient (95%CI) b-coefficient (95%CI) 
Parental longevity (yes vs. no) 0.38* (0.06; 0.71) 0.58 (-0.10; 1.26) 
Age (per 1 year) -0.08 (-0.02; -0.002) -0.01 (-0.03; 0.008) 
Sex (males vs. females) 0.53*** (0.34; 0.71) 0.72*** (0.40; 1.04) 
Living alone (yes vs. no) -0.17* (-0.33; -0.008) -0.19 (-0.47; 0.08) 
Former smoking habits (yes vs. no) 0.13 (-0.06; 0.32) 0.21 (-0.10; 0.53) 
Alcohol consumption (yes vs. no) 0.49*** (0.34; 0.64) 0.60*** (0.35; 0.86) 
Maternal CVD history (yes vs. no) - - -0.04 (-0.31; 0.21) 
Paternal CVD history (yes vs. no) - - 0.25 (-0.02; 0.54) 
Abbreviations: CI: confidence interval. 
* p<0.05, ** p<0.01, *** p<0.001  
 
